The Age-related Changes of Energy Metabolism in Physically Fit Adult Males

Sponsor
Poznan University of Physical Education (Other)
Overall Status
Completed
CT.gov ID
NCT05113914
Collaborator
(none)
420
1
1
107.6
3.9

Study Details

Study Description

Brief Summary

The influence of age and physical fitness level on the level of energy metabolism and antioxidant capacity in adult males.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Cardio-pulmonary exercise test
N/A

Detailed Description

Over four hundred healthy, adult males of different age categories and physical fitness levels were included in the study. There is much research convincing that in athletes of various sports disciplines the level of energy metabolism, oxidative stress, and amino acid profiles during years of training undergoes sports adaptation. The study aimed to evaluate how age and physical fitness level affects the level of purine metabolites and metabolites of nicotinamide adenine dinucleotide, the level of antioxidant capacity, and amino acid profiles. Investigators hypothesized that there will be an age-related decline in most of the physiological indices, but significant differences will appear regarding the level of an individual's sports adaptation.

Study Design

Study Type:
Interventional
Actual Enrollment :
420 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Basic Science
Official Title:
The Influence of Age and Physical Fitness Level on the Level of Energy Metabolism and Antioxidant Capacity in Adult Males
Actual Study Start Date :
Jan 1, 2011
Actual Primary Completion Date :
Nov 30, 2019
Actual Study Completion Date :
Dec 20, 2019

Arms and Interventions

Arm Intervention/Treatment
Experimental: Healthy, physically fit men

All participants underwent a single CPET test with pre- and post-exercise blood measurements.

Diagnostic Test: Cardio-pulmonary exercise test
An incremental running test was conducted on the treadmill. Initially, the exercise protocol included standing still for 3 min and walking for 3 min at a constant speed of 4 km/h. After this introductory part, the speed was increased to 8 km/h and then every 3 min by 2 km/h until the volitional exhaustion was reached. During all procedure oxygen consumption was measured with the use of a portable breath-by-breath ergospirometer.

Outcome Measures

Primary Outcome Measures

  1. Cardio-respiratory measures [during the intervention]

    Cardiopulmonary exercise test (CPET) was conducted while an incremental running test on the treadmill using a portable breath-by-breath ergospirometer and heart rate monitor.

Secondary Outcome Measures

  1. Blood Lactate level [baseline and immediately after the intervention]

    Lactate concentration was performed by the spectrophotometric enzymatic method.

  2. Plasma purine nucleotides [baseline and immediately after the intervention]

    The plasma purine metabolites were estimated in plasma using high-performance liquid chromatography (HPLC) with UV-VIS detection. Measurements performed: Guanosine, Inosine, Adenosine, Hypoxanthine, Xanthine, Uric Acid, Allantoin, Adenine Nucleotides [adenosine triphosphate (ATP), adenosine diphosphate (ADP), adenosine monophosphate (AMP), inosine monophasphate (IMP)], Guanine Nucleotides [guanosine triphosphate (GTP), guanosine diphosphate (GDP), guanosine monophosphate (GMP)].

  3. Erythrocyte Purine Metabolites [baseline and immediately after the intervention]

    The erythrocyte purine metabolites were estimated in erythrocytes using high-performance liquid chromatography (HPLC) with UV-VIS detection. Measurements performed: Adenine Nucleotides [adenosine triphosphate (ATP), adenosine diphosphate (ADP), adenosine monophosphate (AMP), inosine monophasphate (IMP)], Guanine Nucleotides [guanosine triphosphate (GTP), guanosine diphosphate (GDP), guanosine monophosphate (GMP)].

  4. Hypoxanthine-guanine phosphoribosyltransferase (HGPRT) activity [baseline and immediately after the intervention]

    The HGPRT activity was estimated in whole blood and in erythrocytes using high-performance liquid chromatography (HPLC) with UV-VIS detection.

  5. Nicotinamide Adenine Dinucleotide (NAD) and its metabolites [baseline and immediately after the intervention]

    Nicotinamide Adenine Dinucleotide (NAD) and its metabolites were estimated in plasma using mass spectrometric procedure. Measurements performed: Nicotinamide Adenine Dinucleotide (NAD+), Nicotinamide (NA), 1-Methylnicotinamide (MNA), 1-methyl-2-pyridone-5-carboxamide (M2PY), 1-methyl-4-pyridone-5-carboxamide (M4PY), Nicotinamide Mononucleotide (NMN), 4-pyridone-3-carboxamide ribonucleoside (4PYR)

  6. Total antioxidant status (TAS) [baseline]

    Total antioxidant status (TAS) measurement was performed using commercially available ELISA immunoassay.

  7. Thiobarbituric-acid-reactive substances (TBARS) [baseline]

    The measurement of thiobarbituric-acid-reactive substances (TBARS) was performed using commercially available ELISA immunoassay.

  8. Malondialdehyde (MDA) [baseline]

    The measurement of malondialdehyde (MDA) was performed using commercially available ELISA immunoassay.

  9. Polyphenols [baseline]

    The measurement of polyphenols was performed using commercially available ELISA immunoassay.

  10. Reduced glutathione (GSH) [baseline]

    The measurement of reduced glutathione (GSH) was performed using commercially available ELISA immunoassay.

  11. Glutathione peroxidase (GPx) activity [baseline]

    The measurement of glutathione peroxidase (GPx) activity was performed using commercially available ELISA immunoassay.

  12. Aminoacid profile [baseline]

    The levels of 20 aminoacids were estimated in plasma using mass spectrometric procedure.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. healthy

  2. non-smoking

  3. physically fit, including top-level athletes

Exclusion Criteria:
  1. no reported history of a cardiopulmonary or renal diseases, and other chronic diseases

  2. no major orthopedic injury or illness resulting in an inability to run

  3. no medications that could affect cardiopulmonary functions

  4. normal resting electrocardiogram

  5. body mass index (BMI) below 30.0 kg·m-2

  6. normal erythrocyte count and Hb content

  7. no pathological states known of significantly elevated adenylate pool and concentration of ATP, e.g. sickle cell disease, diabetes, leukemia, sepsis, tuberculosis, meningococcal infection, or renal insufficiency

Contacts and Locations

Locations

Site City State Country Postal Code
1 Poznan University of Physical Education Poznań Poland 61-871

Sponsors and Collaborators

  • Poznan University of Physical Education

Investigators

  • Principal Investigator: Jacek Zieliński, Prof., Poznan University of Physical Education

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Poznan University of Physical Education
ClinicalTrials.gov Identifier:
NCT05113914
Other Study ID Numbers:
  • AWF_LA_MA865862
First Posted:
Nov 9, 2021
Last Update Posted:
Nov 16, 2021
Last Verified:
Sep 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Poznan University of Physical Education

Study Results

No Results Posted as of Nov 16, 2021